Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
IDF destroys regime's missile, sea mine production site in Yazd amid nationwide airstrikes - 2New movies to watch this weekend: See 'Predator: Badlands' in theaters, rent 'Black Phone 2,' stream Guillermo del Toro's 'Frankenstein' on Netflix
- 37 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide
- 4An Excursion Through Renowned Western Network programs
- 5Favored Chinese Dish: Make Your Determination
- Humpback whale freed by rescuers in Baltic Sea has become stranded again
- Blue Origin safely launches wheelchair user to space and back
- They want better health care — so they're turning to crypto startups
- Grasping the Qualifications Among Separation and Dissolution
- British Columbia's Secret Lakeside Town With Hot Springs Is 'An Oasis Of Arts, Culture And Relaxation'
- It Shouldn’t Be Here: Rescuers Race to Save Whale Stranded in Rare Spot
- The most effective method to Shield Your Gold Ventures: Procedures and Precautionary measures
- Germany to create restitution council to return colonia-era acquired cultural artefacts
- The Fate of Mechanical technology: 5 Headways Forming Tomorrow
